Evidence map›Paper›PMID 33287304›Full record

ReviewInternational journal of molecular sciences2020

Progress and Insights in the Application of MXenes as New 2D Nano-Materials Suitable for Biosensors and Biofuel Cell Design.

Simonas Ramanavicius, Arunas Ramanavicius

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Review
  2. Controlled Vapor-Phase Synthesis of VSeNanomaterials (Basel, Switzerland) · 2025
    Article
  3. Review
  4. Article
  5. Review
  6. TiHeliyon · 2024
    Article
  7. MXene-Based Chemo-Sensors and Other Sensing Devices.Nanomaterials (Basel, Switzerland) · 2024
    Review
  8. Review
  9. Review
  10. Article
  11. Assessment ofBiosensors · 2022
    Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Two-dimensional TiJournal of nanobiotechnology · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Simonas RamanaviciusCenter for Physical Sciences and Technology (FTMC), Sauletekio av. 3, LT-10257 Vilnius, Lithuania.
Arunas RamanaviciusInstitute of Chemistry, Department of Physical Chemistry, Faculty of Chemistry and Geosciences, Vilnius University, Naugarduko 24, LT-03225 Vilnius, Lithuania.ORCID 0000-0002-0885-3556

Funding

Lietuvos Mokslo Taryba S-MIP-20-18
6 · The paper itself

Abstract

Recent progress in the application of new 2D-materials-MXenes-in the design of biosensors, biofuel cells and bioelectronics is overviewed and some advances in this area are foreseen. Recent developments in the formation of a relatively new class of 2D metallically conducting MXenes opens a new avenue for the design of conducting composites with metallic conductivity and advanced sensing properties. Advantageous properties of MXenes suitable for biosensing applications are discussed. Frontiers and new insights in the area of application of MXenes in sensorics, biosensorics and in the design of some wearable electronic devices are outlined. Some disadvantages and challenges in the application of MXene based structures are critically discussed.

Indexed as

Bioelectric Energy SourcesBiosensing TechniquesNanostructuresNanotechnologyCatalysisElectrodesEnzymesProteinsStatic ElectricityEnzymesProteins2D-nanomaterials2D-nanoparticlesantibodiesbioelectrochemistrycatalytic electrochemical biosensorsenzymatic biofuel cellsimmunosensorsmicrobial biofuel cellsMXenesnonstoichiometric titanium oxides TiO2−x/TiO2 and TinO2n−1redox enzymes

Identifiers

PMID33287304
PMCPMC7730251

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.